Thioredoxin-like domains required for glucose regulatory protein 58-mediated reductive activation of mitomycin C leading to DNA cross-linking

Molecular Cancer Therapeutics

Volumn 6, Issue 10, 2007, Pages 2719-2727

  Adikesavan, Anbu Karani ^a   Jaiswal, Anil K ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; GLUCOSE REGULATED PROTEIN; GLUCOSE REGULATED PROTEIN 58; MITOMYCIN C; THIOREDOXIN; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CHO CELL; CLONING; COLON CARCINOMA; DNA CROSS LINKING; ENZYME INHIBITION; MAMMAL CELL; MUTAGENESIS; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; CROSS-LINKING REAGENTS; DNA; DNA DAMAGE; HUMANS; INSULIN; MITOMYCIN; MOLECULAR CHAPERONES; MUTAGENESIS, SITE-DIRECTED; MUTAGENS; NADP; PROTEIN DISULFIDE-ISOMERASE; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; THIOREDOXINS;

EID: 35848968258     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-0160     Document Type: Article

References (19)

1. Hirano N, Shibasaki F, Sakai R, et al. Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase: identification of its secretory form and inducible expression by the oncogenic transformation. Eur J Biochem 1995;234:336-42.
2. Bourdi M, Demady D, Martin JL, et al. cDNA cloning and baculovirus expression of the human liver endoplasmic reticulum P58: characterization as a protein disulfide isomerase isoform, but not as a protease or a carnitine acyltransferase. Arch Biochem Biophys 1995;323:397-403.
3. Lee AS. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 2001;26:504-10.
4. Briquet-Laugier V, Xia Y-R, Rooke K, et al. Mapping of three members of the mouse protein disulfide isomerase family. Mamm Genome 1998;9:176-7.
5. Antoniou AN, Ford S, Alphey M, et al. The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I molecules. EMBO J 2002;21:2655-63.
6. Joseph CE, Chakravarthi S, Garbi N, et al. ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. EMBO J 2007;26:28-40.
7. Coppari S, Altieri F, Ferraro A, et al. Nuclear localization and DNA interaction of protein disulfide isomerase ERp57 in mammalian cells. J Cell Biochem 2002;85:325-33.
8. Ferraro A, Altieri F, Coppari S, et al. Binding of the protein disulfide isomerase isoform ERp60 to the nuclear matrix-associated regions of DNA. J Cell Biochem 1999;72:528-39.
9. Ndubuisi MI, Guo GG, Fried VA, et al. Cellular physiology of STAT3: where's the cytoplasmic monomer? J Biol Chem 1999;274:25499-509.
10. Workman P. Enzyme-directed bioreductive drug development revisited: A commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase. Oncol Res 1994;6:461-75.
11. Naylor MA, Thomson P. Recent advances in bioreductive drug targeting. Mini Rev Med Chem 2001;1:17-29.
12. Schellens JH, Dombernowsky P, Cassidy J, et al. Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9. Anticancer Drugs 2001;12:583-90.
13. Loadman PM, Bibby MC, Phillips RM. Pharmacological approach towards the development of indoloquinones bioreductive drugs based on the clinically inactive agent EO9. Br J Pharmacol 2002;137:701-9.
14. Verweij J, Pinedo HH, Mitomycin C. In: Cancer chemotherapy and biological modifiers. Pinedo HM, Cabner BA, Longo DL, editors. Annual 11. Amsterdam; Elsevier Science Publishers: 1990. p. 63-73.
15. Celli M, Jaiswal AK. Role of GRP58 in mitomycin C-induced DNA cross-linking. Cancer Res 2003;63:6016-25.
16. Takeiri A, MIshima M, Tanaka K, et al. Molecular characterization of mitomycin C-induced large deletions and tandem-base substitutions in the bone marrow of gptδ transgenic mice. Chem Res Toxicol 2003;16:171-9.
17. Chichiarelli S, FerraroA , Altieri F, et al. The stress protein ERp57/GRP58 binds specific DNA sequences in HeLa cells. J Cell Physiol 2007;210:343-51.
18. Grillo C, D'Ambrosio C, Consalvi V, et al., DNA-binding activity of the ERp57 C-terminal domain is related to a redox-dependent conformational change. J Biol Chem 2007;282:10299-310.
19. Tomida A, Tsuruo T. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Design 1999;14:169-77.